MedTrace Logo

Effect Insulin Pump Therapy to Patients With Diabetic Nephropathy

NCT03174821 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2017-06-05

No results posted yet for this study

Summary

The recent study suggested that oxidative stress resulting from increased production of reactive oxygen species (ROS) plays a crucial role in the development of diabetic complications. The researches aim to monitor the level of oxidative stress of patient in different stage of diabetic nephropathy before and after insulin pump therapy.

Conditions

  • Insulin Pump Therapy in Treating Diabetic Nephropathy

Interventions

DEVICE

Insulin pump

Blood glucose management device

Sponsors & Collaborators

  • Chinese PLA General Hospital

    lead OTHER

Principal Investigators

  • Min Liu · Center for Drug Evaluation, China food and Drug Administration

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-20
Primary Completion
2014-05-16
Completion
2014-05-16

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03174821 on ClinicalTrials.gov